Kidney-type glutaminase (GLS1) is a biomarker for pathologic diagnosis and prognosis of hepatocellular carcinoma

The lack of sensitive and specific biomarkers hinders pathological diagnosis and prognosis for hepatocellular carcinoma (HCC). Since glutaminolysis plays a crucial role in carcinogenesis and progression, we sought to determine if the expression of kidney-type and liver-type glutaminases (GLS1 and GL...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Decai, Shi, Xianbiao, Meng, Gang, Chen, Jun, Yan, Chen, Jiang, Yong, Wei, Jiwu, Ding, Yitao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480704/
https://www.ncbi.nlm.nih.gov/pubmed/25844758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480704/
https://www.ncbi.nlm.nih.gov/pubmed/25844758

Ejemplares similares